Real-world effectiveness and safety of lanadelumab for prophylaxis of hereditary angioedema attacks: 2-year interim results from the enable study

被引：0
|
作者：
Saguer, I. Martinez [1 ]
Cancian, M. [2 ]
Kinaciyan, T. [3 ]
Kessel, A. [4 ]
Andriotti, T. [5 ]
Botha, J. [6 ]
Wuillemin, W. [7 ,8 ]
机构：
[1] HRZM Hemophilia Ctr Rhein Main, Morfelden Walldorf, Germany
[2] Univ Hosp Padua, Padua, Italy
[3] Med Univ Vienna, Vienna, Austria
[4] Technion Fac Med, Bnai Zion Med Ctr, Haifa, Israel
[5] Takeda Dev Ctr Amer Inc, Lexington, KY USA
[6] Takeda Pharmaceut Int AG, Zurich, Switzerland
[7] Luzerner Kantonsspital, Luzern, Switzerland
[8] Univ Bern, Bern, Switzerland
来源：
ALLERGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
000847
引用
收藏
页码：27 / 28
页数：2
相关论文
共 50 条
  • [1] Lanadelumab for the prevention of hereditary angioedema attacks: A real-world UK audit
    Dorr, Anthony D.
    Chopra, Charu
    Coulter, Tanya I.
    Dempster, John
    Dziadzio, Magdalena
    El-Shanawany, Tariq
    Garcez, Tomaz
    Gompels, Mark
    Herriot, Richard
    Jain, Rashmi
    Levi, Marcel
    Lorenzo, Lorena
    Makki, Inas
    Mapazire, Elizabeth
    Murng, Sai H. K.
    Noorani, Sadia
    Savic, Sinisa
    Steele, Cathal L.
    Symons, Christine
    Tarzi, Michael
    Yong, Patrick F. K.
    Kiani-Alikhan, Sorena
    ALLERGY, 2023, 78 (05) : 1369 - 1371
  • [2] Real-World Effectiveness of Lanadelumab in Hereditary Angioedema: Multicountry INTEGRATED Observational Study
    Magerl, Markus
    Bouillet, Laurence
    Martinez-Saguer, Inmaculada
    Gavini, Francois
    Bent-Ennakhil, Nawal
    Sayegh, Laura
    Andresen, Irmgard
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2025, 13 (02):
  • [3] Lanadelumab Effectiveness and Safety in Adolescent Patients With Hereditary Angioedema Aged 12 to <18 Years: Pooled Results From the Real-World ENABLE and EMPOWER Studies
    Tachdjian, Raffi
    Banerji, Aleena
    Busse, Paula
    Agmon-Levin, Nancy
    Anderson, John
    Cancian, Mauro
    Spadaro, Giuseppe
    Enciu, Carmen
    Estepan, Daniel Nova
    Khutoryansky, Natalie
    Recke, Andreas
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB78 - AB78
  • [4] Evaluation of long-term effectiveness of lanadelumab for hereditary angioedema in real-world clinical practice: Design of the ENABLE study
    Martinez, Saguer, I
    Kinaciyan, T.
    Magerl, M.
    Wuillemin, W. A.
    Mendivil, J.
    Giannattasio, G.
    Maurer, M.
    ALLERGY, 2020, 75 : 202 - 203
  • [5] Real-world Treatment Outcomes of Lanadelumab in the Prevention of Hereditary Angioedema Attacks: an Interim Analysis of a Polish, Prospective, Multicenter, Observational Study (CHOPIN)
    Kucharczyk, Aleksandra
    Matuszewski, Tomasz
    Kurowski, Marcin
    Juchacz, Aldona
    Tomasial-Lozowska, Maria
    Trebas-Pietras, Ewa
    Pawlowicz, Robert
    Sokolowska, Malgorzata
    Pawlukiewicz, Magorzata
    Zakrzewska, Magdalena
    Kuziemski, Krzysztof
    Tykwinska, Marta
    Lukaszyk, Mateusz
    Drygala, Syzmon
    Kasprzak, Jakub
    Porebski, Grzegorz
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB9 - AB9
  • [6] Real-world outcomes in patients with hereditary angioedema prescribed lanadelumab versus other prophylaxis
    Anderson, John
    Soteres, Daniel
    Tachdjian, Raffi
    Mellor, Jennifer
    Earl, Lucy
    Connolly, Hannah
    Wynne-Cattanach, Kieran
    Moran, Kellyn
    Sing, Krystal
    Schultz, Bob G.
    Juethner, Salome
    ALLERGY AND ASTHMA PROCEEDINGS, 2024, 45 (06) : 426 - 433
  • [7] Real-world safety and effectiveness of voretigene neparvovec: Year 3 interim results from the PERCEIVE study
    Fischer, M. Dominik
    Simonelli, Francesca
    Audo, Isabelle S.
    Leroy, Bart Peter
    Kessel, Line
    Marques, Joao Pedro
    Bjelos, Mirjana
    Bainbridge, James
    Aoun, Manar
    Maier, Rainer
    Khan, Rehna
    Clemens, Andreas
    Holz, Frank G.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [8] Effectiveness of lanadelumab for preventing hereditary angioedema attacks: Subgroup analyses from the HELP study
    Johnston, Douglas T.
    Busse, Paula J.
    Riedl, Marc A.
    Maurer, Marcus
    Anderson, John
    Nurse, Christina
    Inhaber, Neil
    Yu, Ming
    Banerji, Aleena
    CLINICAL AND EXPERIMENTAL ALLERGY, 2021, 51 (10): : 1391 - 1395
  • [9] LONG-TERM SAFETY OF LANADELUMAB IN HEREDITARY ANGIOEDEMA (HAE): INTERIM RESULTS FROM THE HELP OLE STUDY
    Johnston, D.
    Banerji, A.
    Nurse, C.
    Lu, P.
    Aygoren-Pursun, E.
    Kiani-Alikhan, S.
    Soteres, D.
    Lugar, P.
    Zuraw, B.
    Lockey, R.
    Schwartz, L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S30 - S30
  • [10] LANADELUMAB FOR PREVENTION OF ATTACKS IN HEREDITARY ANGIOEDEMA: RESULTS FROM THE PHASE 3 HELP STUDY
    Banerji, A.
    Riedl, M.
    Bernstein, J.
    Cicardi, M.
    Longhurst, H.
    Zuraw, B.
    Maurer, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S5 - S5
12345